Newsletter Signup | Join Community
Kyprolis® superior to Velcade® in patients with relapsed Multiple Myeloma.
Further Findings Show Pomalyst plus Low-Dose Dexamethasone Safe and Effective in Relapsed or Refractory Multiple Myeloma
Ninlaro - effective treatment for multiple myeloma & promising for maintenance - convenient with minimal side effect
Diagnosed with Multiple Myeloma: 10 Tips on How to Get The Most From Your Doctor
Dr. Bill Benisnger M.D. of Swedish Cancer Inst. discusses the growing number of treatment options for Multiple Myeloma
ICARIA-MM trial demonstrated Isatuximab improves progression free survival in advanced Multiple Myeloma.
Stay Current With Multiple Myeloma Treatment Advances & Connect with Others
Empliciti combined with Revlimid or Pomalyst delays progression and prolongs survival in recurrent multiple myeloma.
Dr. Craig Hofmeister, MD guest-moderated on CancerConnect for a question-and-answer session in the Multiple Myeloma
Sarah Holstein, MD, PhD from Roswell Park Cancer Institute answered questions on multiple myeloma: join the conversation
Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is…
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed. …
UK doctors identify a new target for treating Multiple Myeloma: …